Cargando…
Cannabinoid receptor type 2 (CB2)-selective N-aryl-oxadiazolyl-propionamides: synthesis, radiolabelling, molecular modelling and biological evaluation
BACKGROUND: The endocannabinoid system is involved in many physiological and pathological processes. Two receptors (cannabinoid receptor type 1 (CB1) and type 2 (CB2)) are known so far. Many unwanted psychotic side effects of inhibitors of this system can be addressed to the interaction with CB1. Wh...
Autores principales: | Rühl, Thomas, Deuther-Conrad, Winnie, Fischer, Steffen, Günther, Robert, Hennig, Lothar, Krautscheid, Harald, Brust, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598492/ https://www.ncbi.nlm.nih.gov/pubmed/23067874 http://dx.doi.org/10.1186/2191-2858-2-32 |
Ejemplares similares
-
Radiofluorination and biological evaluation of N-aryl-oxadiazolyl-propionamides as potential radioligands for PET imaging of cannabinoid CB(2) receptors
por: Teodoro, Rodrigo, et al.
Publicado: (2013) -
Development of cannabinoid receptor (CB 2 R) ligands for application in PET studies - where to attach the radiolabel?
por: Günther, Robert, et al.
Publicado: (2014) -
A 3D-QSAR model for cannabinoid receptor (CB2) ligands derived from aligned pharmacophors
por: Günther, Robert, et al.
Publicado: (2013) -
Synthesis and Preliminary Biological Evaluation of Indol-3-yl-oxoacetamides as Potent Cannabinoid Receptor Type 2 Ligands
por: Moldovan, Rareş-Petru, et al.
Publicado: (2017) -
Synthesis, Structure–Activity
Relationships,
Radiofluorination, and Biological Evaluation of [(18)F]RM365,
a Novel Radioligand for Imaging the Human Cannabinoid Receptor Type
2 (CB2R) in the Brain with PET
por: Teodoro, Rodrigo, et al.
Publicado: (2023)